World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
25477
World Ranking
13266
National Ranking
415

Roland Chapurlat publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Roland Chapurlat sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 540 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Roland Chapurlat D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Roland Chapurlat sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Roland Chapurlat is affiliated with Claude Bernard University Lyon 1 in France. Their research primarily focuses on medicine, with particular specialization in orthopedics and sports medicine, rheumatology, surgery, oncology, and physiology. The scientist's work consistently engages with topics related to bone health and osteoporosis research, bone health and treatments, hip and femur fractures, bone and joint diseases, rheumatoid arthritis research and therapies, nutrition and health in aging, and bone tumor diagnosis and treatments.

Their publication record includes notable recent papers such as:

  • Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography, 2020, Osteoporosis International
  • The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions, 2021, Osteoporosis International
  • Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan, 2022, Osteoporosis International
  • Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial, 2021, Journal of Bone and Mineral Research
  • Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX, 2023, Osteoporosis International

Frequent co-authors collaborating with Roland Chapurlat include:

  • Paweł Szulc
  • Elisabeth Sornay-Rendu
  • Blandine Merle
  • Éric Lespessailles
  • Emmanuel Biver

Their research has been featured prominently in key publication venues, including:

  • Revue du Rhumatisme
  • Journal of Bone and Mineral Research
  • Osteoporosis International
  • Bone Reports
  • Bone

This profile presents Roland Chapurlat's contributions across multiple medical subfields centered on skeletal health and disease, highlighting a consistent publication activity and collaboration within their research network.

Best Publications

  • 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

    Henry G Bone;Rachel B Wagman;Maria L Brandi;Jacques P Brown

  • A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX.

    Eugene V McCloskey;Anders Odén;Nicholas C Harvey;William D Leslie

  • Obesity is not protective against fracture in postmenopausal women: GLOW.

    Juliet E. Compston;Nelson B. Watts;Roland D. Chapurlat;Cyrus Cooper

  • Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review.

    Charlotte Beaudart;Charlotte Beaudart;A. Dawson;S. C. Shaw;Nicholas C. Harvey

  • A meta-analysis of the association of fracture risk and body mass index in women

    Helena Johansson;John A. Kanis;Anders Odén;Eugene McCloskey

  • Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension.

    Socrates Papapoulos;Roland Chapurlat;Cesar Libanati;Maria Luisa Brandi

  • Republished: Value of biomarkers in osteoarthritis: current status and perspectives

    M. Lotz;Johanne Martel-Pelletier;Claus Christiansen;Maria Luisa Brandi

  • Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

    Jean-Yves Reginster;Janusz Badurski;Nicholas Bellamy;William Bensen

  • Value of biomarkers in osteoarthritis: current status and perspectives

    M. Lotz;Johanne Martel-Pelletier;Claus Christiansen;Maria Luisa Brandi

  • Long‐Term Effects of Intravenous Pamidronate in Fibrous Dysplasia of Bone

    Roland D. Chapurlat;Pierre D. Delmas;Daniel Liens;Pierre J. Meunier

  • Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study

    Elizabeth J Samelson;Kerry E Broe;Hanfei Xu;Laiji Yang

  • The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension.

    Henry G. Bone;Roland D Chapurlat;Maria-Luisa Brandi;Jacques P Brown

  • Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).

    Juliet E. Compston;Julie M. Flahive;David W. Hosmer Jr.;Nelson B. Watts

  • Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study

    S. Boutroy;D. Hans;E. Sornay-Rendu;N. Vilayphiou

  • Impact of Prevalent Fractures on Quality of Life: Baseline Results From the Global Longitudinal Study of Osteoporosis in Women

    Jonathan D. Adachi;Silvano Adami;Stephen H. Gehlbach;Frederick A. Anderson Jr.

  • A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density

    Eric Orwoll;Christence S Teglbjærg;Bente Lomholt Langdahl;Roland Chapurlat

  • Bone remodelling in humans is load-driven but not lazy

    Patrik Christen;Patrik Christen;Keita Ito;Rafaa Ellouz;Stephanie Boutroy

  • Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study

    Henrik Toft Sørensen;Steffen Christensen;Frank Mehnert;Lars Pedersen

  • Fibrous dysplasia of bone and McCune-Albright syndrome.

    Roland D. Chapurlat;Philippe Orcel

  • 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis

    Karine Briot;Bernard Cortet;Thierry Thomas;Maurice Audran

Frequent Co-Authors

Cyrus Cooper
Cyrus Cooper University of Southampton
Jean-Yves Reginster
Jean-Yves Reginster University of Liège
Jonathan D. Adachi
Jonathan D. Adachi McMaster University
Juliet E. Compston
Juliet E. Compston University of Cambridge
Kenneth G. Saag
Kenneth G. Saag University of Alabama at Birmingham
Susan L. Greenspan
Susan L. Greenspan University of Pittsburgh
Adolfo Diez-Perez
Adolfo Diez-Perez Autonomous University of Barcelona
Steven Boonen
Steven Boonen KU Leuven
Olivier Bruyère
Olivier Bruyère University of Liège

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying medicine in the USA opens the door to a wide range of related degrees and healthcare career opportunities. Many students complement or pivot their pathways by exploring specialized online programs, making advanced education more flexible and accessible.

If you are interested in health management or leadership roles within hospitals, consider health administration degrees online. These programs teach essential skills for healthcare operations and management across clinical and non-clinical settings. For graduates seeking to advance or accelerate their administrative career, cheapest online mha programs offer an affordable and flexible way to earn a master’s degree in the field.

Practicing nurses aiming for a leadership or clinical specialist role should explore cheap online dnp programs. These advanced degrees prepare nurses for top patient care and executive roles. Similarly, for those drawn to pharmacy, online pharmacy programs can pave the way towards becoming a licensed pharmacist with the flexibility of remote study.

These online programs make it possible to balance your studies with work or other commitments, while pursuing meaningful and high-demand health careers.

Best Scientists Citing Roland Chapurlat

Trending Scientists

Recently Published Articles